Loading...
Price History
Market Data
| Market Cap | 13.04B |
| P/E Ratio | 19.84 |
| P/B Ratio | - |
| EPS | 9.84 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 1.29 |
| Currency | USD |
Key Financial Metrics
13.64B
Revenue
746.80M
Net Income
9.84
EPS (Diluted)
1.59B
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
15.0%
Net Profit Margin
5.5%
EBITDA
2.75B
Returns & Efficiency
Return on Assets (ROA)
4.3%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
9.84
Financial Health
Total Assets
17.48B
Total Debt
10.16B
Debt to Equity
-
Current Ratio
1.29
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Net Value:
-182.86M
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | DENVER, CO |
| Fiscal Year | 2025 |
Peers
SOTERA HEALTH CO
SHC
4.48B
P/E: 92.5
2.01B
P/E: 142.9
PROGYNY, INC.
PGNY
1.47B
P/E: 40.7
860.49M
P/E: --
463.98M
P/E: --
349.63M
P/E: 25.0
162.30M
P/E: --
162.30M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$13.04B
P/E Ratio (TTM)19.8
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin15.0%
Net Margin5.5%
ROE-
ROA4.3%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.29
Total Debt$10.16B
Total Assets$17.48B
Stockholders' Equity$-651.08M
Income Statement (FY 2025)
Revenue$13.64B
Gross Profit-
Operating Income$2.04B
Net Income$746.80M
EPS (Diluted)$9.84
Cash Flow (FY 2025)
Free Cash Flow$1.59B
Cash & Equivalents$676.44M
Revenue Growth6.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 2000 16TH STREET DENVER, CO 80202 |
| Phone | 310-536-2668 |
| Incorporated | DE, US |
| EIN | 510354549 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 66.80M |
| Stockholders' Equity | $-651.08M |
| Cash & Equivalents | $676.44M |
Recent Filings
View All
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-07
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-05
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-22
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-22
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-22
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-17
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | DAVITA INC. |
| Ticker | DVA |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | DENVER, CO |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 13.04B |
| Revenue | 13.64B |
| Net Income | 746.80M |
| P/E Ratio | 19.84 |
| EPS | 9.84 |
| Net Margin | 5.5% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...